Stock Scorecard



Stock Summary for Bio-Techne Corp (TECH) - $50.13 as of 6/19/2025 8:41:31 PM EST

Total Score

10 out of 30

Safety Score

50 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for TECH

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for TECH

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for TECH

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for TECH

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for TECH (50 out of 100)

Stock Price Rating (Max of 10) 9
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 5
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 1
Operating Margin (Max of 10) 3
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 2
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for TECH

Exosome Research Market is expected to generate a revenue of USD 646.52 Million by 2032, Globally, at 13.93% CAGR: Verified Market Research® 6/19/2025 2:15:00 PM
This PVH Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Commercial Metals ( NYSE:CMC ) , Brixmor Property Group ( NYSE:BRX ) 5/30/2025 2:36:00 PM
What Does the Market Think About Bio-Techne? - Bio-Techne ( NASDAQ:TECH ) 5/29/2025 7:00:00 PM
Is Bio-Techne Stock the Right Pick for Your Portfolio Now? 5/29/2025 12:47:00 PM
Bio-Techne Q3 Earnings & Revenues Top Estimates, Stock Up in Premarket 5/7/2025 2:05:00 PM
Is the Options Market Predicting a Spike in BioTechne Stock? 5/7/2025 12:34:00 PM
This House of Representative Just Bought Up To $195K In Bio-Techne Stock - Bio-Techne ( NASDAQ:TECH ) , Dayforce ( NYSE:DAY ) 5/5/2025 3:00:00 PM
TECH Gears Up to Report Q3 Earnings: Here's What to Expect 4/30/2025 11:51:00 AM
Strength Seen in Bio-Techne ( TECH ) : Can Its 10.8% Jump Turn into More Strength? 4/10/2025 12:40:00 PM
This PTC Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Host Hotels & Resorts ( NASDAQ:HST ) , Health Catalyst ( NASDAQ:HCAT ) 4/9/2025 12:32:00 PM

Financial Details for TECH

Company Overview

Ticker TECH
Company Name Bio-Techne Corp
Country USA
Description Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for the global clinical diagnostic and research markets. The company is headquartered in Minneapolis, Minnesota.
Sector Name LIFE SCIENCES
Industry Name BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Most Recent Quarter 3/31/2025
Next Earnings Date N/A

Stock Price History

Last Day Price 50.13
Price 4 Years Ago 127.26
Last Day Price Updated 6/19/2025 8:41:31 PM EST
Last Day Volume 2,164,765
Average Daily Volume 2,652,130
52-Week High 83.21
52-Week Low 45.94
Last Price to 52 Week Low 9.12%

Valuation Measures

Trailing PE 61.88
Industry PE 60.81
Sector PE 40.43
5-Year Average PE 46.16
Free Cash Flow Ratio 55.70
Industry Free Cash Flow Ratio 19.08
Sector Free Cash Flow Ratio 31.51
Current Ratio Most Recent Quarter 3.71
Total Cash Per Share 0.90
Book Value Per Share Most Recent Quarter 12.87
Price to Book Ratio 3.89
Industry Price to Book Ratio 18.89
Sector Price to Book Ratio 30.07
Price to Sales Ratio Twelve Trailing Months 6.50
Industry Price to Sales Ratio Twelve Trailing Months 46.69
Sector Price to Sales Ratio Twelve Trailing Months 34.41
Analyst Buy Ratings 8
Analyst Strong Buy Ratings 3

Share Statistics

Total Shares Outstanding 156,767,000
Market Capitalization 7,858,729,710
Institutional Ownership N/A

Dividends

Ex-Dividend Date 5/19/2025
Previous Dividend Amount 0.0800
Current Dividend Amount 0.0800
Total Years Dividend Increasing 0
Trailing Annual Dividend Rate 0.32
Trailing Annual Dividend Yield 0.65%
Forward Annual Dividend Rate 0.32
Forward Annual Dividend Yield 0.65%
5-Year Dividend Payments Count 20
3-Year Average Dividend Yield 0.45%
5-Year Average Dividend Yield 0.38%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 1.59%
Dividend Payout Ratio 37.65%

Income Statement

Quarterly Earnings Growth YOY -54.80%
Annual Earnings Growth -41.07%
Reported EPS 12 Trailing Months 0.80
Reported EPS Past Year 1.40
Reported EPS Prior Year 1.78
Net Income Twelve Trailing Months 131,666,000
Net Income Past Year 168,105,000
Net Income Prior Year 285,263,000
Quarterly Revenue Growth YOY 4.20%
5-Year Revenue Growth 10.17%
Operating Margin Twelve Trailing Months 14.10%

Balance Sheet

Total Cash Most Recent Quarter 140,670,000
Total Cash Past Year 151,791,000
Total Cash Prior Year 180,571,000
Net Cash Position Most Recent Quarter -189,330,000
Net Cash Position Past Year -167,209,000
Long Term Debt Past Year 319,000,000
Long Term Debt Prior Year 350,000,000
Total Debt Most Recent Quarter 330,000,000
Equity to Debt Ratio Past Year 0.87
Equity to Debt Ratio Most Recent Quarter 0.86
Total Stockholder Equity Past Year 2,068,850,000
Total Stockholder Equity Prior Year 1,966,516,000
Total Stockholder Equity Most Recent Quarter 2,018,025,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 220,755,000
Free Cash Flow Per Share Twelve Trailing Months 1.41
Free Cash Flow Past Year 236,104,000
Free Cash Flow Prior Year 216,149,000

Options

Put/Call Ratio 0.29
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal -0.53
20-Day Bollinger Lower Band 39.77
20-Day Bollinger Middle Band 56.45
20-Day Bollinger Upper Band 73.12
Beta 1.38
RSI 55.54
50-Day SMA 67.41
150-Day SMA 72.83
200-Day SMA 81.23

System

Modified 6/19/2025 11:34:46 AM EST